Navigation Links
Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Date:5/21/2008

levels of NT-pro-BNP, a plasma biomarker of cardiac function, in patients receiving inhaled treprostinil as compared to patients receiving placebo. Patients receiving inhaled treprostinil showed a median decrease in NT-pro-BNP levels of 57 pg/ml at 12 weeks, as compared to a median increase of 40 pg/ml at 12 weeks in those patients receiving placebo.

Dr. McLaughlin also highlighted the convenience of inhaled treprostinil, which is administered via four one-minute inhalation sessions per day.

The TRIUMPH-1 (TReprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension) trial was a randomized, double-blind, placebo-controlled trial of patients with severe PAH. The study population consisted of 235 patients who were optimized on an approved oral therapy for PAH, either bosentan (Tracleer(R)), an endothelin receptor antagonist, or sildenafil (Revatio(R)), a phosphodiesterase-5 inhibitor. In addition to one of these oral therapies, patients were administered inhaled treprostinil or placebo in four daily inhalation sessions with a maximum dose of 54 micrograms per session over the course of the 12-week trial.

Oral Treprostinil

In Plasma Levels with Oral Treprostinil Dietholamine over a Wide Range of Doses in Patients with PAH, Dr. R. James White of the University of Rochester presented data from a 12-patient study showing that a sustained-release capsule of treprostinil administered twice daily allowed patients to maintain consistent therapeutic levels of treprostinil in their bloodstreams in an equivalent therapeutic range to intravenously or subcutaneously administered treprostinil. The pharmacokinetic profile demonstrated that the release of treprostinil from the oral dosage form was sustained and supported the twice-daily regimen used in United Therapeutics' ongoing Phase 3 FREEDOM studies of oral treprostinil in patients with PAH. Dr. White's presentation also highlighted that the dose of oral treprostinil admin
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society
2. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
3. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
4. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
5. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
6. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
7. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
8. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
9. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
10. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
11. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 Major pharmaceutical and medical ... a legal conference in Philadelphia on ... issues, Tom Hagy of HB Litigation Conferences has ... visit HB,s website at http://litigationconferences.com/?p=31886 The ... McCambridge Singer & Mahoney and Michelle Hart Yeary ...
(Date:8/27/2015)... Aug. 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first ... the United States in a trial ... stent for blockages in the main artery of the leg. ... and potentially less risk for stent fracture or re-narrowing after ... single-arm, multicenter clinical trial of the BioMimics 3D Stent System ...
(Date:8/27/2015)... 27, 2015 The Elekta Linac-based ... Boston on July 9th for its ... to more fully exploit the potential of advances in ... diseases. "As an established provider of sophisticated ... assume a leadership role - in collaboration with its ...
Breaking Medicine Technology:Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3First Pennsylvania Patient Treated in Landmark Vascular Study 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3
... Ingelheim Pharmaceuticals, Inc. will present new phase Ib data ... annual meeting in Chicago (June 3-7) that indicates combining ... the maximum tested dose controlled disease in all (n=22) ... non-small cell lung cancer (NSCLC) who developed acquired resistance ...
... NEW YORK, May 25, 2011 ... research report is available in its ... Devices Market Outlook in Brazil to ... Infusion Systems, Central Venous Catheters and ...
Cached Medicine Technology:Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 2Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 3Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 4Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 5Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 6Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 7Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 2Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 3Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 4Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 5Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 6Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 7Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 8Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 9Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 10Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 11
(Date:8/27/2015)... ... ... In an article published July 30th by the New York Times, ... a security firm that is tasked with providing supplemental protection. Called the French Quarter ... the city to provide private security when it is needed in a city that ...
(Date:8/27/2015)... ... August 27, 2015 , ... About ... Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds ... to a Georgia State University study. , While most people don’t develop persistent ...
(Date:8/27/2015)... ... August 27, 2015 , ... Healthpointe is proud to welcome Dr. Ted ... Los Angeles. Licensed to practice Chinese Needle Therapy since 1983, Dr. Priebe specializes in ... Dr. Priebe also practices in Healthpointe’s La Mirada clinic and Garden Grove clinic. ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... and leading biopharmaceutical contract development manufacturing company (CDMO), announced today that it has ... for $205.68M in cash. , The addition of Cytovance Biologics to ...
(Date:8/27/2015)... ... ... King Kullen, America’s First Supermarket, is celebrating 85 years of serving the ... recognized by the Smithsonian Institute as America’s First Supermarket, King Kullen changed the grocery ... Kennedy families have created a culture of caring while building their business. Offering ...
Breaking Medicine News(10 mins):Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:King Kullen Honors Their 85 Years of Success this August 2
... vaccines for new flu strains, other health threats ... Researchers have devised a rapid and efficient method ... called monoclonal antibodies, which mark and neutralize foreign ... accelerate the traditionally challenging task of generating human ...
... Healed by Registered Organ and Tissue Donors, ... tissue donors joined organ transplant recipients at the ... the Department of Motor,Vehicles (DMV) and the three ... lives by signing up on the state-authorized Donate ...
... healthy,eating and neonatal jaundice are among the many topics ... the upcoming Pediatric,Academic Societies Meeting in Honolulu May 2-6. ... more information or to reach one of,the researchers, call ... **ALL RESEARCH IS EMBARGOED UNTIL THE DATE AND TIME ...
... JOLLA, CA Diabetic individuals have a significantly ... molecular connection between the two remains unexplained. Now, ... identified the probable molecular basis for the diabetes ... in the current online issue of Neurobiology of ...
... from Allscripts Document Management; Expects ... Clinical & Financial Investment, CHICAGO and FORT ... of clinical software, connectivity and,information solutions that physicians ... Center Medical Group has selected the Allscripts,Electronic Health ...
... Fall Out Boy, Will.i.am, Alyssa Milano, Say Anything,Perez ... Helping Fuel,Game,s Viral Spread, Developed in Partnership ... Personal Stories of Americans Living With and Without,HIV/AIDS, ... Peabody and,Emmy Award-winning college network, and the Kaiser ...
Cached Medicine News:Health News:Researchers Develop Quick Way to Create Human Antibodies 2Health News:Researchers Develop Quick Way to Create Human Antibodies 3Health News:Three Million Californians Say 'Yes!' to Organ and Tissue Donation 2Health News:Three Million Californians Say 'Yes!' to Organ and Tissue Donation 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 2Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 2Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 4Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 2Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 3Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 4Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 5Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 6
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... 3 system consists of the Model 7432 ... MemoryMod Software Cartridge. , ,Enterra™ Therapy ... nausea and vomiting associated with gastroparesis when ... relief of symptons for diabetic or idiopathic ...
... Intramuscular Lead is a unipolar lead intended for ... has a ski needle design for easier use ... a fixed electrode length of 1 cm. The ... is available in 35 cm length. Two leads ...
Medicine Products: